Look here for a clue. There's no foolproof way to know the future for Derma Sciences (Nasdaq: DSCI) or any other company. However, certain clues may help you see potential stumbles before they happen ...

Integra will pay a total of approximately $204 million in cash for the common stock and a price of $32.00 per share for outstanding shares of Series A Convertible Preferred Stock while a $48.00 price ...

Derma Sciences and Quick-Med Technologies announce the signing of an agreement whereby Quick-Med Technologies has granted Derma Sciences an exclusive global license to intellectual property related to ...

Here at The Motley Fool, I've long cautioned investors to keep a close eye on inventory levels. It's a part of my standard diligence when searching for the market's best stocks. I think a quarterly ...

PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced a $7.0 million strategic investment in ...

Wound-care products maker Derma Sciences Inc. said today it has raised $6.1 million in gross proceeds under agreements to sell the company’s stocks and warrants to new and existing ...

BANGALORE – Derma Sciences Inc said foot ulcers in 85 percent of diabetic patients healed completely after being treated with its experimental drug at the end of a 24-week trial, improving its chances ...